| Autor: |
Gulizia, Michele M., Puig, Juan Garcia, Calvo, Carlos, Luurila, Olavi, Luurila, Harri, Sulosaari, Sakari, Strandberg, Arto, Ghezzi, Cristina |
| Zdroj: |
Current News in Cardiology; 2007, p441-444, 4p |
| Abstrakt: |
Several trials have shown that hypertensive patients whose blood pressure (BP) is brought under control (< 140/90 mmHg) have significantly fewer cardiovascular events than patients whose BP remains uncontrolled [1]. However, despite the availability of multiple antihypertensive drugs, BP is difficult to control, especially systolic BP and in elderly patients [2]. In most clinical trials aimed at controlling BP, more than two antihypertensive drugs are almost always required. The importance of combination therapy has been emphasized in current guidelines [3]. Adding a second antihypertensive drug may be a better option in non-controlled patients than switching to a different drug or increasing the dose of the first compound. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
